Larvol Delta - Efficacy-Safety-and-Tolerability-of-CS0159-Combined-With-Semaglutide-in-MAFLD-Patients-With-Obesity-and-T2DM

linafexor (CS0159) - Cascade Pharma

http://clinicaltrials.gov/ct2/show/NCT07570810

May 7, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next